WTX-212C
/ Westlake Therap
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 15, 2026
WTX-212C-IIT: Allogeneic WTX-212C in Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=24 | Recruiting | Sponsor: Zhejiang Provincial People's Hospital | Not yet recruiting ➔ Recruiting
Enrollment open • Tumor mutational burden • Oncology • Solid Tumor • PD-L1
1 to 1
Of
1
Go to page
1